Bruce A. Freeman
Chief Executive Officer at Creegh Pharmaceuticals, Inc.
Profile
Bruce A.
Freeman is the founder of Complexa, Inc. founded in 2008.
He is currently the President, Chief Executive Officer & Director at Creegh Pharmaceuticals, Inc. and also serves as the Chairman-Department of Pharmacology at the University of Pittsburgh.
Dr. Freeman received his undergraduate and doctorate degrees from the University of California, Riverside.
Bruce A. Freeman active positions
Companies | Position | Start |
---|---|---|
University of Pittsburgh | Corporate Officer/Principal | - |
Creegh Pharmaceuticals, Inc.
Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Chief Executive Officer | - |
Former positions of Bruce A. Freeman
Companies | Position | End |
---|---|---|
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Founder | - |
Training of Bruce A. Freeman
University of California, Riverside | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
Creegh Pharmaceuticals, Inc.
Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Health Technology |
- Stock Market
- Insiders
- Bruce A. Freeman